How Transepithelial Electrical Resistance Is Used in Permeation-Enhancer Research

Transepithelial electrical resistance, or TEER, is used in permeation-enhancer research as a functional measure of how strongly an epithelial model resists ionic movement across the cell layer. Researchers record TEER before enhancer exposure, follow changes while the enhancer is present, and may continue measurements after removal to determine whether barrier resistance recovers. A reduction in TEER can be consistent with increased paracellular permeability, but it does not identify the transport pathway by itself and cannot distinguish controlled junctional opening from broader barrier damage without supporting measurements.

TEER is especially useful within permeation-enhancer research for peptide oral films because it provides a rapid, repeatable barrier measurement that can be followed over time. Unlike a terminal protein assay, TEER can show how an epithelial layer behaves before, during, and after exposure to an experimental formulation.

Research-use notice: This article explains how transepithelial electrical resistance is used in permeation-enhancer research, including baseline barrier measurement, TEER reduction, recovery, paracellular permeability, peptide transport, and interpretation of epithelial integrity. InStrips products are supplied only for research and analytical evaluation and are not intended to diagnose, treat, cure, or prevent epithelial barrier disorders, oral or mucosal conditions, peptide deficiencies, absorption disorders, digestive disease, injury, or any other medical condition.

A reduction in TEER does not establish safe barrier opening, greater human peptide bioavailability, selective paracellular transport, clinical effectiveness, appropriate administration, or suitability for any person.

What TEER Actually Measures

TEER measures electrical resistance across an epithelial barrier.

Researchers apply a small electrical signal and determine how strongly the epithelial system resists ionic conduction.

The result is commonly normalized to the area of the epithelial layer.

TEER Is Usually Reported as Resistance Times Area

Area normalization allows comparison between culture inserts of different sizes.

The general unit is commonly expressed as:

ohm × cm²

Exact values depend heavily on the epithelial model.

High and Low TEER Are Relative Concepts

A naturally tight epithelial model can have much higher baseline resistance than a more permeable mucosal model.

Researchers should therefore compare:

• the same model
• the same culture conditions
• the same measurement system

rather than treating one universal TEER value as normal.

Buccal Models Are Different From Intestinal Models

TR146 and other oral epithelial models do not necessarily produce the same baseline resistance as:

• Caco-2 intestinal cells
• airway epithelium
• renal epithelium

Numerical thresholds should remain tissue- and model-specific.

Baseline TEER Is Measured Before Enhancer Exposure

Researchers first establish whether the epithelial layer has formed a reasonably stable barrier.

This helps identify:

• poorly developed cultures
• damaged inserts
• unusual experimental wells

A Stable Baseline Improves Interpretation

If TEER is already falling before enhancer addition, a subsequent decrease cannot be attributed confidently to the enhancer.

Time-matched untreated controls are therefore important.

Enhancer Exposure Can Be Followed Continuously or at Intervals

Researchers may record TEER:

• immediately before exposure
• minutes after exposure
• at several later intervals
• after washout

This generates a barrier-response curve.

The Shape of the TEER Curve Can Be Informative

Several patterns are possible.

For example:

• rapid fall followed by recovery
• gradual decline
• small transient reduction
• persistent low resistance

These patterns can imply different barrier responses.

A Rapid Reversible Drop Can Support Temporary Modulation

If TEER decreases during enhancer exposure and returns toward baseline after removal, this can be consistent with a temporary increase in epithelial permeability.

It does not prove molecularly specific tight-junction opening.

A Persistent TEER Reduction Requires More Caution

If resistance remains low, researchers need to consider:

• persistent junctional alteration
• cell injury
• membrane disruption
• loss of cell attachment

Magnitude of TEER Reduction Is Not a Direct Measure of Peptide Flux

A 50% decline in electrical resistance does not mean peptide permeability increased by 50%.

Ions and peptides differ greatly in:

• size
• charge
• diffusion behavior

This Is One of the Most Important Limits of TEER

TEER primarily reflects ionic conductance.

It does not directly quantify movement of:

• a peptide
• dextran
• another macromolecule

Peptide Transport Must Be Measured Directly

Researchers may therefore pair TEER with:

• receiver-side peptide concentration
• cumulative permeation
• apparent permeability coefficient

Marker Molecules Add a Bridge Between Ions and Peptides

Hydrophilic marker molecules can provide an intermediate measurement of paracellular transport.

Markers may include:

• mannitol
• fluorescent dextrans
• other poorly transcellular probes

Molecular Size Series Are Particularly Informative

Researchers can compare permeability of markers such as:

• small hydrophilic compounds
• 4 kDa dextran
• 10 kDa dextran
• 20 kDa dextran

This helps determine whether an enhancer changes only small-solute permeability or creates a broader macromolecular pathway.

Buccal Chitosan Studies Provide a Useful Example

TR146 epithelial research has shown that chitosan-related enhancers can decrease TEER while increasing transport of hydrophilic markers.

Permeability decreased as dextran molecular size increased, illustrating that a more open barrier can remain size-selective.

This Supports a More Nuanced Interpretation Than “Junctions Opened”

The data can indicate:

• greater paracellular accessibility
• continued size restriction

at the same time.

TEER Is Sensitive to Experimental Temperature

Electrical resistance can change with temperature.

Measurements made at:

• room temperature
• incubator temperature

may not be directly comparable.

Temperature Should Therefore Be Standardized

Repeated measurements need consistent conditions to avoid interpreting temperature-related variation as barrier modulation.

Culture Medium Composition Can Affect TEER

Electrical conductivity depends partly on:

• ions
• buffer composition
• medium volume

Enhancer formulations can change these variables independently of the epithelium.

Formulation Conductivity Can Confound the Measurement

A highly conductive enhancer solution can reduce measured resistance even if epithelial structure changes only modestly.

Researchers therefore need appropriate:

• blank formulations
• vehicle controls
• medium controls

Electrode Position Matters

TEER measurements can vary if electrodes are placed differently relative to the cell layer.

Standardized geometry reduces measurement variability.

Air Bubbles Can Distort Readings

Bubbles near:

• the epithelial surface
• electrodes

can create unstable or inaccurate resistance measurements.

Repeated Measurement Technique Matters

Researchers need consistent procedures for:

• electrode sterilization
• placement
• equilibration
• reading duration

Blank Insert Resistance Must Be Accounted For

The support membrane and fluid have their own electrical resistance.

Researchers generally subtract the resistance of a cell-free insert before calculating the epithelial contribution.

Cell Confluence Influences Baseline TEER

An incomplete epithelial layer can show low resistance because cells have not formed a continuous barrier.

This should not be mistaken for enhancer-induced permeability.

Cell Differentiation Can Change TEER Over Time

As cultured epithelial cells mature, their:

• junctional organization
• barrier properties

may change.

Experiments should therefore use comparable culture ages.

TEER Can Reveal Acute Toxicity but Cannot Define It Alone

A severe sudden fall can be consistent with cell damage.

However, toxicity needs separate measurements.

Cell Viability Assays Provide Complementary Evidence

Researchers may examine:

• metabolic activity
• membrane integrity
• cell death

after enhancer exposure.

A Normal Viability Assay Does Not Guarantee Normal Junctional Function

Cells can remain alive while showing substantially increased paracellular permeability.

Barrier function therefore needs its own measurements.

Microscopy Helps Explain TEER Changes

Researchers can stain:

• occludin
• claudins
• ZO-1

to determine whether reduced resistance corresponds with junctional redistribution.

TEER and Junctional Imaging Answer Different Questions

TEER asks:

Did functional electrical resistance change?

Imaging asks:

Did junctional organization change visibly?

The strongest interpretation can come from agreement between the two.

Western Blotting Adds Protein-Abundance Information

If TEER falls while total junctional protein remains stable, redistribution or signaling may be more important than protein loss.

Phosphorylation Studies Can Add an Acute Signaling Mechanism

A rapid permeability change may involve modification of existing proteins rather than slower changes in protein expression.

TEER Can Be Used to Compare Enhancer Concentrations

Researchers may test:

• low concentration
• intermediate concentration
• higher concentration

and observe whether barrier resistance changes progressively.

Concentration-Response Does Not Establish an Optimal Condition Automatically

The highest concentration may produce:

• the largest TEER decrease
• the largest marker flux

while also producing:

• slower recovery
• greater cell stress

Recovery Can Be Quantified as a Percentage of Baseline

After enhancer removal, researchers may follow resistance until it:

• returns near baseline
• partially recovers
• remains persistently reduced

Recovery Time Is an Important Endpoint of Its Own

Two enhancers can produce the same initial TEER drop but very different recovery patterns.

This can indicate different effects on epithelial barrier regulation.

Repeated Exposure May Change Recovery

An epithelial layer that recovers fully after one exposure may show:

• slower recovery
• larger TEER loss

after repeated treatment.

Repeated-use models therefore ask a separate research question.

TEER Recovery Does Not Prove Complete Tissue Recovery

Electrical resistance can normalize while other cellular changes remain.

Researchers may therefore also examine:

• protein localization
• gene expression
• cell viability

TEER Is Most Straightforward in Monolayer Models

Uniform cell-culture inserts provide a well-defined area and electrical pathway.

Thick stratified tissues introduce more complex electrical properties.

Ex-Vivo Buccal Tissue Can Still Be Studied Electrically

But absolute values may depend strongly on:

• tissue thickness
• connective tissue
• electrode configuration
• tissue preparation

Cross-Model TEER Numbers Should Not Be Compared Directly

A value from TR146 cells should not be treated as quantitatively interchangeable with:

• porcine buccal tissue
• human buccal tissue
• intestinal Caco-2 cells

TEER Is Especially Useful for Temporal Experiments

Its strongest advantage is that it can be measured repeatedly without destroying the epithelial model.

This allows researchers to follow the sequence:

baseline → enhancer exposure → maximum barrier change → washout → recovery

Terminal Assays Can Be Added at Selected Points

After completing TEER measurements, researchers may collect cells or tissue for:

• protein analysis
• microscopy
• histology

This Creates a Multi-Layered Barrier Assessment

For example:

• TEER measures functional electrical resistance
• dextran measures molecular transport
• microscopy measures junctional organization
• viability measures cellular injury

No Single Endpoint Can Replace the Others

A permeation-enhancer study is strongest when several measurements agree while also identifying any conflicting signals.

TEER Reduction Is Not Equivalent to Peptide Absorption

Even if TEER falls substantially, the peptide may still be limited by:

• molecular size
• mucus interaction
• enzymatic degradation
• formulation release

A Small TEER Change Can Sometimes Accompany Measurable Peptide Transport

If the enhancer changes a highly relevant local pathway, a large electrical change may not be necessary.

This is another reason TEER magnitude should not be used as a direct proxy for peptide flux.

A Large TEER Change Can Occur Without Useful Selectivity

A severely compromised barrier may conduct ions readily and allow many molecules to pass.

That does not represent controlled permeation enhancement.

Marker Molecules Provide the Next Interpretive Step

Because TEER measures ionic resistance rather than macromolecular passage, researchers frequently pair it with defined paracellular marker molecules of known size and hydrophilicity.

That strategy is examined in how paracellular marker molecules help researchers evaluate barrier opening.

What TEER Does Not Establish

A TEER change does not by itself establish:

• which molecular pathway opened
• how much intact peptide crossed
• whether barrier alteration was selective
• whether tissue changes were fully reversible
• high human systemic bioavailability
• clinical effectiveness
• an appropriate amount for human use

Final Perspective

Transepithelial electrical resistance is a useful functional tool because it allows researchers to monitor epithelial barrier behavior repeatedly before, during, and after permeation-enhancer exposure.

A TEER decrease can support evidence of increased epithelial permeability, especially when accompanied by greater paracellular marker or peptide transport. But electrical resistance measures ion conductance rather than peptide movement and cannot distinguish controlled junctional modulation from barrier damage on its own.

Accurate interpretation should therefore combine TEER with molecular transport, junctional-protein analysis, viability, and recovery rather than treating a low resistance value as proof of effective or appropriate peptide delivery.